DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Vision - Removing the barriers to vascularized composite allotransplantation (VCA)

Reconstructive Transplant Research  Program Cover Image
The Reconstructive Transplant Research (RTR) Program was initiated in 2012 to advance the science and execution of complex hand, face and other vascularized composite allotransplantation (VCA) procedures.

Many factors related to weaponry, personal protection, and trauma care during Operations Enduring Freedom and Iraqi Freedom resulted in greater survival of those sustaining increasingly severe combat injuries, particularly injuries to the face and the extremities. The intent of the RTR program is to advance the field of VCA to make the procedure possible for a broader population of patients, and to restore our wounded warriors to duty or to meaningful lives. The RTR program was initiated in 2012 to fund innovative projects in an array of topic areas within the field of VCA. Beneficiaries of the techniques and technologies developed with this funding include injured Service Members, Veterans, their caregivers, and family members, as well as civilians who have suffered catastrophic tissue loss.


Congressional Appropriations

Congressional Appropriations

  • $57 million
    FY12-16
  • $12 million
    FY17

Funding Summary

Funding
Summary

Peer Review Participants

Peer Review Participants


news_icon News & Highlights

Vision

Removing the barriers to vascularized composite allotransplantation (VCA)

Mission

Delivering innovative solutions in the field of vascularized composite allotransplantation to restore form, function, and appearance to those who have been catastrophically injured.


Last updated Tuesday, June 6, 2017